Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis
✍ Scribed by J. Dorst; P. Kühnlein; C. Hendrich; J. Kassubek; A. D. Sperfeld; A. C. Ludolph
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 226 KB
- Volume
- 258
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We have shown that linear estimates of rates of disease progression (LEP), derived from isometric myometry [grip or foot dorsiflexion (FD) strength] and forced vital capacity (FVC%), are clinically and statistically significant predictors of survival of patients with amyotrophic lateral sclerosis (A
to worsening of parkinsonian symptoms. Because Verhagen and co-workers [3] do not provide confirmation of their lesion locations, it is conceivable that their lesions encroached on the GPe. The second point raised by Krack and colleagues, is not really relevant, since it seems to apply solely to DB
The authors report a patient with disseminated malignant teratoma who has survived for 3.5 years after discontinuation of treatment despite a persistent and nonprogressive elevation of his serum alpha-fetoprotein level. Potential sources of the marker in his case are discussed and the possibility of